Impact of Alginate Composition: From Bead Mechanical Properties to Encapsulated HepG2/C3A Cell Activities for In Vivo Implantation

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Capone, Stephanie H ^a,b   Dufresne, Murielle ^a   Rechel, Mathias ^a   Fleury, Marie José ^a   Salsac, Anne Virginie ^a   Paullier, Patrick ^a   Daujat Chavanieu, Martine ^b   Legallais, Cecile ^a  

^a UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; COLLAGEN TYPE 1; NANOBEAD; ALBUMINOID; CALCIUM; CYANOCOBALAMIN; GLUCOSE; GLUCURONIC ACID; HEXURONIC ACID; MICROCAPSULE; MICROSPHERE; POLYLYSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL ENCAPSULATION; CELL ENGINEERING; CELL FUNCTION; CELL LINE; CELL PROLIFERATION; CELL STRAIN C3A; CELL STRAIN HEPG2; CELL TRANSPLANTATION; CELL VIABILITY; CELL WALL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MATERIALS TESTING; MICROENCAPSULATION; MOLECULAR STABILITY; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; POROSITY; YOUNG MODULUS; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HEPG2 CELL LINE; MECHANICS; METABOLISM; MICROCAPSULE; PROCEDURES;

MUS;

ALBUMINS; ALGINATES; ANIMALS; CALCIUM; CAPSULES; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; COLLAGEN TYPE I; FEMALE; GLUCOSE; GLUCURONIC ACID; HEP G2 CELLS; HEXURONIC ACIDS; HUMANS; MATERIALS TESTING; MECHANICAL PROCESSES; MICE; MICROSPHERES; POLYLYSINE; VITAMIN B 12;

EID: 84876733410     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062032     Document Type: Article

References (52)

1. Carpentier B, Gautier A, Legallais C, (2009) Artificial and bioartificial liver devices: present and future. Gut 58(12): 1690-1702.
2. Strom S, Fisher R, (2003) Hepatocyte transplantation: new possibilities for therapy. Gastroenterology 124(2): 568-571.
3. Dhawan A, Puppi J, Hughes RD, Mitry RR, (2010) Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 7(5): 288-298.
4. Selden C, Hodgson H, (2004) Cellular therapies for liver replacement. Transpl Immunol 12(3-4): 273-288.
5. Gupta S, Vasa SR, Rajvanshi P, Zuckier LS, Palestro CJ, et al. (1997) Analysis of hepatocyte distribution and survival in vascular beds with cells marked by 99mTC or endogenous dipeptidyl peptidase IV activity. Cell Transplant 6(4): 377-386.
6. Aoki T, Jin Z, Nishino N, Kato H, Shimizu Y, et al. (2005) Intrasplenic transplantation of encapsulated hepatocytes decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats. Transplantation 79(7): 783-790.
7. Mei J, Sgroi A, Mai G, Baertschiger R, Gonelle-Gispert C, et al. (2009) Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice. Cell Transplant 18(1): 101-110.
8. Grasdalen H, Larsen B, Smidsrød O, (1979) A p.m.r. study of the composition and sequence of uronate residues in alginates. Carbohydrate Research 68(1): 23-31.
9. Kohn R, Larsen B, (1972) Preparation of water-soluble polyuronic acids and their calcium salts, and the determination of calcium ion activity in relation to the degree of polymerization. Acta Chem Scand 26(6): 2455-2468.
10. Shoichet MS, Li RH, White ML, Winn SR, (1996) Stability of hydrogels used in cell encapsulation: An in vitro comparison of alginate and agarose. Biotechnol Bioeng 50(4): 374-381.
11. Orive G, Ponce S, Hernández RM, Gascón AR, Igartua M, et al. (2002) Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates. Biomaterials 23(18): 3825-3831.
12. Zimmermann U, Thürmer F, Jork A, Weber M, Mimietz S, et al. (2001) A novel class of amitogenic alginate microcapsules for long-term immunoisolated transplantation. Ann NY Acad Sci 944: 199-215.
13. Shulman M, Nahmias Y, (2013) Long-term culture and coculture of primary rat and human hepatocytes. Methods Mol Biol 945: 287-302.
14. Yongsunthon R, Baker WA, Bryhan MD, Baker DE, Chang T, et al. (2009) Force spectroscopy of hepatocytic extracellular matrix components. Ultramicroscopy 109(8): 942-947.
15. Fassett JT, Tobolt D, Nelsen CJ, Albrecht JH, Hansen LK, (2003) The role of collagen structure in mitogen stimulation of ERK, cyclin D1 expression, and G1-S progression in rat hepatocytes. J Biol Chem 278(34): 31691-31700.
16. Quek CH, Li J, Sun T, Chan ML, Mao HQ, et al. (2004) Photo-crosslinkable microcapsules formed by polyelectrolyte copolymer and modified collagen for rat hepatocyte encapsulation. Biomaterials 25: 3531-3540.
17. Ng S, Wu YN, Zhou Y, Toh YE, Ho ZZ, et al. (2005) Optimization of 3-D hepatocyte culture by controlling the physical and chemical properties of the extracellular matrices. Biomaterials 26: 3153-3163.
18. Tam SK, Bilodeau S, Dusseault J, Langlois G, Hallé J-P, et al. (2011) Biocompatibility and physicochemical characteristics of alginate-polycation microcapsules. Acta Biomater 7(4): 1683-1692.
19. Strand BL, Ryan TL, In't Veld P, Kulseng B, Rokstad AM, et al. (2001) Poly-L-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant 10(3): 263-275.
20. Rokstad AM, Brekke O-L, Steinkjer B, Ryan L, Kolláriková G, et al. (2011) Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model. Acta Biomater 7(6): 2566-2578.
21. King A, Strand B, Rokstad A-M, Kulseng B, Andersson A, et al. (2003) Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating. J Biomed Mater Res A 64(3): 533-539.
22. Lee M, Lo AC, Cheung PT, Wong D, Chan BP, (2009) Drug carrier systems based on collagen-alginate composite structures for improving the performance of GDNF-secreting HEK293 cells. Biomaterials 30: 1214-1221.
23. de Vos P, Bucko M, Gemeiner P, Navrátil M, Svitel J, et al. (2009) Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 30(13): 2559-2570.
24. Harm S, Strobl K, Hartmann J, Falkenhagen D, (2009) Alginate-encapsulated human hepatoma C3A cells for use in a bioartificial liver device - the hybrid-MDS. Int J Artif Organs 32(11): 769-778.
25. Mavri-Damelin D, Damelin LH, Eaton S, Rees M, Selden C, et al. (2008) Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia. Biotechnol Bioeng 99(3): 644-651.
26. Khalil M, Shariat-Panahi A, Tootle R, Ryder T, McCloskey P, et al. (2001) Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function. J Hepatol 34(1): 68-77.
27. Selden C, Shariat A, McCloskey P, Ryder T, Roberts E, et al. (1999) Three-dimensional in vitro cell culture leads to a marked upregulation of cell function in human hepatocyte cell lines-an important tool for the development of a bioartificial liver machine. Ann N Y Acad Sci 875: 353-363.
28. Rahman TM, Selden C, Khalil M, Diakanov I, Hodgson HJ, (2004) Alginate-encapsulated human hepatoblastoma cells in an extracorporeal perfusion system improve some systemic parameters of liver failure in a xenogeneic model. Artif Organs 28(5): 476-482.
29. Coward SM, Legallais C, David B, Thomas M, Foo Y, et al. (2009) Alginate-encapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma. Artif Organs 33(12): 1117-1126.
30. David B, Dufresne M, Nagel M-D, Legallais C, (2004) In vitro assessment of encapsulated C3A hepatocytes functions in a fluidized bed bioreactor. Biotechnol Prog 20(4): 1204-1212.
31. David B, Barbe L, Barthès-Biesel D, Legallais C, (2006) Mechanical properties of alginate beads hosting hepatocytes in a fluidized bed bioreactor. Int J Artif Organs 29(8): 756-763.
32. Knaebel A, Rebre SR, Lequeux F, (1997) Determination of the elastic modulus of superabsorbent gel beads. Polymer Gels and Networks 5(2): 107-121.
33. Hertz H, (1882) Ueber die Berührung fester elastischer Körper. Journal für die reine und angewandte Mathematik (Crelles Journal) 1882: 156-171.
34. David B, Doré E, Jaffrin MY, Legallais C, (2004) Mass transfers in a fluidized bed bioreactor using alginate beads for a future bioartificial liver. Int J Artif Organs 27(4): 284-293.
35. Lewińska D, Rosiński S, Hunkeler D, Poncelet D, Weryński A, (2002) Mass transfer coefficient in characterization of gel beads and microcapsules. J Memb Sci 209(2): 533-540.
36. Chia SM, Leong KW, Li J, Xu X, Zeng K, et al. (2000) Hepatocyte encapsulation for enhanced cellular functions. Tissue Eng 6(5): 481-495.
37. Gautier A, Carpentier B, Dufresne M, Vu Dinh Q, Paullier P, et al. (2011) Impact of alginate type and bead diameter on mass transfers and the metabolic activities of encapsulated C3A cells in bioartificial liver applications. Eur Cell Mater 21: 94-106.
38. Li RH, (1998) Materials for immunoisolated cell transplantation. Adv Drug Deliv Rev 33(1-2): 87-109.
39. Catapano G, (1996) Mass transfer limitations to the performance of membrane bioartificial liver support devices. Int J Artif Organs 19(1): 18-35.
40. Saudek F, Jirák D, Girman P, Herynek V, Dezortová M, et al. (2010) Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation 90(12): 1602-1606.
41. Vandenbossche GM, Van Oostveldt P, Demeester J, Remon JP, (1993) The molecular weight cut-off of microcapsules is determined by the reaction between alginate and polylysine. Biotechnol Bioeng 42(3): 381-386.
42. Hallé JP, Leblond FA, Landry D, Fournier A, Chevalier S, (1992) Studies of 300-microns microcapsules: I. Use of arginine esterase release by microencapsulated prostatic cells as a measure of membrane permeability. Transplant Proc 24(6): 2930-2932.
43. Kulseng B, Thu B, Espevik T, Skjåk-Braek G, (1997) Alginate polylysine microcapsules as immune barrier: permeability of cytokines and immunoglobulins over the capsule membrane. Cell Transplant 6(4): 387-394.
44. Gillette BM, Jensen JA, Wang M, Tchao J, Sia SK, (2010) Dynamic hydrogels: switching of 3D microenvironments using two-component naturally derived extracellular matrices. Adv Mater Weinheim 22(6): 686-691.
45. Rahman TM, Diakanov I, Selden C, Hodgson H, (2005) Co-transplantation of encapsulated HepG2 and rat Sertoli cells improves outcome in a thioacetamide induced rat model of acute hepatic failure. Transpl Int 18(8): 1001-1009.
46. Kinasiewicz A, Gautier A, Lewinska D, Smietanka A, Legallais C, et al. (2008) Three-dimensional growth of human hepatoma C3A cells within alginate beads for fluidized bioartificial liver. Int J Artif Organs 31(4): 340-347.
47. Tran NM, Dufresne M, Duverlie G, Castelain S, Défarge C, et al. (2013) An appropriate selection of 3D alginate culture model for hepatic Huh-7 cell line encapsulation intended for viral studies. Tissue Eng Part A 19(1-2): 103-13.
48. Ben-Ze'ev A, Robinson GS, Bucher NL, Farmer SR, (1988) Cell-cell and cell-matrix interactions differentially regulate the expression of hepatic and cytoskeletal genes in primary cultures of rat hepatocytes. Proc Natl Acad Sci U S A 85(7): 2161-2165.
49. Ijima H, Ogata R, Murasawa Y, Wang PC, (2010) Albumin production activity of primary rat hepatocytes is improved on type V collagen. J Biosci Bioeng 109(2): 179-181.
50. Gao Y, Xu J, Sun B, Jiang HC, (2004) Microencapsulated hepatocytes and islets as in vivo bioartificial liver support system. World J Gastroenterol 10(14): 2067-2071.
51. Qiu L, Wang J, Wen X, Wang H, Wang Y, et al. (2012) Transplantation of co-microencapsulated hepatocytes and HUVECs for treatment of fulminant hepatic failure. Int J Artif Organs 35(6): 458-65.
52. Teng Y, Wang Y, Li S, Wang W, Gu R, et al. (2010) Treatment of acute hepatic failure in mice by transplantation of mixed microencapsulation of rat hepatocytes and transgenic human fetal liver stromal cells. Tissue Eng Part C 16(5): 1125-1134.